Literature DB >> 7304554

Nicotine exposure and Parkinson disease.

D G Haack, R J Baumann, H E McKean, H D Jameson, J A Turbek.   

Abstract

The observed inverse relationship between smoking and Parkinson disease has prompted suggestions that nicotine, a centrally active agent, might protect against the disease. In this case-control study, cases were found to have ever regularly smoked cigarettes significantly less frequently than sex-, race-, and age-matched neighbors. This report analyzes the detailed smoking histories of cases and neighbors to see if these histories support the nicotine protection hypothesis. Estimated nicotine exposure before age at onset of symptoms for smoking cases was 186.1 g; for smoking controls it was 208.3 g (p = 0.34). Among the cases, severity of disease was not related to the extent of nicotine exposure before disease onset. Age at onset of symptoms for smoking cases (52.7 years) was not delayed (57.8 years for nonsmoking cases). Since the study was unable th find further support for the nicotine protection hypothesis, it is concluded that the observed inverse relationship between smoking and Parkinson disease is likely explainable by other factors, such as selective mortality or pre-morbid behavioral and/or constitutional changes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7304554     DOI: 10.1093/oxfordjournals.aje.a113182

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

Review 1.  How far are we in understanding the cause of Parkinson's disease?

Authors:  Y Ben-Shlomo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

2.  Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women.

Authors:  Natalia Palacios; Xiang Gao; Eilis O'Reilly; Michael Schwarzschild; Marjorie L McCullough; Tinisha Mayo; Susan M Gapstur; Alberto A Ascherio
Journal:  Mov Disord       Date:  2012-06-19       Impact factor: 10.338

3.  Parkinson's disease and CYP1A2 activity.

Authors:  J T Forsyth; R A Grünewald; A Rostami-Hodjegan; M S Lennard; H J Sagar; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

Review 4.  Idiopathic Parkinson's disease: epidemiology, diagnosis and management.

Authors:  Y Ben-Shlomo; K Sieradzan
Journal:  Br J Gen Pract       Date:  1995-05       Impact factor: 5.386

Review 5.  Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease.

Authors:  J R James; A Nordberg
Journal:  Behav Genet       Date:  1995-03       Impact factor: 2.805

6.  A meta-analysis of tea drinking and risk of Parkinson's disease.

Authors:  Feng-Jiao Li; Hong-Fang Ji; Liang Shen
Journal:  ScientificWorldJournal       Date:  2012-02-15

7.  Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson's disease.

Authors:  Carolin Gabbert; Inke R König; Theresa Lüth; Beke Kolms; Meike Kasten; Eva-Juliane Vollstedt; Alexander Balck; Anne Grünewald; Christine Klein; Joanne Trinh
Journal:  J Neurol       Date:  2022-03-02       Impact factor: 6.682

8.  Determination of Nicotine in Tobacco by Chemometric Optimization and Cation-Selective Exhaustive Injection in Combination with Sweeping-Micellar Electrokinetic Chromatography.

Authors:  Yi-Hui Lin; Chia-Hsien Feng; Shih-Wei Wang; Po-Yun Ko; Ming-Hsun Lee; Yen-Ling Chen
Journal:  J Anal Methods Chem       Date:  2015-05-26       Impact factor: 2.193

Review 9.  Epidemiology of Parkinson's disease.

Authors:  C M Tanner
Journal:  Neurol Clin       Date:  1992-05       Impact factor: 3.806

Review 10.  Epidemiology of Parkinson's disease.

Authors:  C M Tanner; S M Goldman
Journal:  Neurol Clin       Date:  1996-05       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.